Alisha A. Mohamed-Hadley, Ph.D.
Affiliations: | 2011 | Molecular Biology and Genetics | Temple University, Philadelphia, PA, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Alisha Mohamed-Hadley"Parents
Sign in to add mentorBarbara Hoffman | grad student | 2011 | Temple University | |
(The role of the stress response gene Gadd45a in modulating Myc mediated apoptosis and differentiation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Liebermann DA, Tront JS, Sha X, et al. (2011) Gadd45 stress sensors in malignancy and leukemia. Critical Reviews in Oncogenesis. 16: 129-40 |
Mohamed-Hadley AA, Liebermann D. (2010) Stress Response Gadd45a Gene Functions as Tumor Suppressor In MYC Expressing Myeloid Cells Modulating Apoptosis and Cytokine Receptor Expression. Blood. 116: 1556-1556 |
Hoffman B, Mohamed-Hadley A, Liebermann D. (2010) Abstract 3099: Stress response gadd45a gene as tumor suppressor in MYC expressing myeloid cells is cytokine specific Cancer Research. 70: 3099-3099 |
Mohamed-Hadley AA, Liebermann DA, Hoffman B. (2009) Stress Response Gadd45a Gene as Tumor Suppressor in MYC Expressing Myeloid Cells Is Cytokine Specific. Blood. 114: 1481-1481 |
Mohamed-Hadley A, Gibbs JD, Liebermann DA, et al. (2007) Gadd45a Behaves as a Tumor Suppressor and Gadd45b Behaves as an Oncogene in myc-Mediated Block in Myeloid Differentiation. Blood. 110: 4163-4163 |
Gibbs JD, Mohamed-Hadley A, Liebermann DA, et al. (2007) Gadd45 Genes Participate in Myeloid Cell Fate Determination. Blood. 110: 4043-4043 |
Benencia F, Courrèges MC, Conejo-García JR, et al. (2005) HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 789-802 |
Conejo-Garcia JR, Benencia F, Courreges MC, et al. (2003) Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biology & Therapy. 2: 446-51 |